GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » EV-to-FCF

Nobel Biocare Holding AG (Nobel Biocare Holding AG) EV-to-FCF : 25.00 (As of May. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Nobel Biocare Holding AG's Enterprise Value is $2,235.1 Mil. Nobel Biocare Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2013 was $89.4 Mil. Therefore, Nobel Biocare Holding AG's EV-to-FCF for today is 25.00.

The historical rank and industry rank for Nobel Biocare Holding AG's EV-to-FCF or its related term are showing as below:

NBHGF's EV-to-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 28.96
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Nobel Biocare Holding AG's stock price is $18.25. Nobel Biocare Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2013 was $0.479. Therefore, Nobel Biocare Holding AG's PE Ratio for today is 38.10.


Nobel Biocare Holding AG EV-to-FCF Historical Data

The historical data trend for Nobel Biocare Holding AG's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG EV-to-FCF Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 24.93 14.58 7.97 18.37

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nobel Biocare Holding AG's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nobel Biocare Holding AG's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's EV-to-FCF falls into.



Nobel Biocare Holding AG EV-to-FCF Calculation

Nobel Biocare Holding AG's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2235.090/89.405
=25.00

Nobel Biocare Holding AG's current Enterprise Value is $2,235.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nobel Biocare Holding AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2013 was $89.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nobel Biocare Holding AG  (OTCPK:NBHGF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Nobel Biocare Holding AG's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=18.25/0.479
=38.10

Nobel Biocare Holding AG's share price for today is $18.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nobel Biocare Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2013 was $0.479.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Nobel Biocare Holding AG EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines